Robert N Helsley
Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic Lerner College of Medicine, Cleveland, United States
Competing interests
Robert N Helsley, reports being a paid consultant for the University of Cincinnati..
Tatsunori Miyata
Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic Lerner College of Medicine, Cleveland, United States
Competing interests
No competing interests declared.
Anagha Kadam
Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic Lerner College of Medicine, Cleveland, United States
Competing interests
No competing interests declared.
Varadharajan Venkateshwari
Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic, Cleveland, United States
Competing interests
No competing interests declared.
Naseer Sangwan
Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic Lerner College of Medicine, Cleveland, United States
Competing interests
No competing interests declared.
Emily C. Huang
Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic Lerner College of Medicine, Cleveland, United States
Competing interests
No competing interests declared.
Rakhee Banerjee
Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic Lerner College of Medicine, Cleveland, United States
Competing interests
No competing interests declared.
Amanda L Brown
Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic Lerner College of Medicine, Cleveland, United States
Competing interests
No competing interests declared.
Kevin K Fung
Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic Lerner College of Medicine, Cleveland, United States
Competing interests
No competing interests declared.
William Massey
Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic Lerner College of Medicine, Cleveland, United States
Competing interests
No competing interests declared.
Chase Neumann
Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic, Cleveland, United States
Competing interests
No competing interests declared.
Orabi Danny
Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic, Cleveland, United States
Competing interests
No competing interests declared.
Lucas J Osborn
Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic Lerner College of Medicine, Cleveland, United States
Competing interests
No competing interests declared.
Rebecca C Schugar
Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic Lerner College of Medicine, Cleveland, United States
Competing interests
No competing interests declared.
Megan R. McMullen
Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic, Cleveland, United States
Competing interests
No competing interests declared.
Annette Bellar
Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic Lerner College of Medicine, Cleveland, United States
Competing interests
No competing interests declared.
Kyle L. Poulsen
Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic, Cleveland, United States
Competing interests
Kyle L. Poulsen, Grant support from NIH.
Adam Kim
Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic Lerner College of Medicine, Cleveland, United States
Competing interests
No competing interests declared.
Vai Pathak
Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic, Cleveland, United States
Competing interests
No competing interests declared.
Marko Mrdjen
Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic, Cleveland, United States
Competing interests
No competing interests declared.
James T Anderson
Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic Lerner College of Medicine, Cleveland, United States
Competing interests
No competing interests declared.
Belinda Willard
Research Core Services, Cleveland Clinic Lerner College of Medicine, Cleveland, United States
Competing interests
No competing interests declared.
Craig J. McClain
University of Louisville, Louisville, United States
Competing interests
No competing interests declared.
Mack Mitchell
The University of Texas Southwestern Medical Center, Dallas, United States
Competing interests
No competing interests declared.
Arthur J. McCullough
Research Core Services, Cleveland Clinic Lerner College of Medicine, Cleveland, United States
Competing interests
No competing interests declared.
Svetlana Radaeva
National Institute of Health, Bethesda, United States
Competing interests
No competing interests declared.
Bruce Barton
University of Massachusetts Medical School, Worcester, United States
Competing interests
No competing interests declared.
Gyongyi Szabo
Beth Israel Deaconess Medical Center, Boston, United States
Competing interests
Gyongyi Szabo, G.S. reports being a paid consult for Allergan, Alnylam, Arrow, Durcect Corporation, Generon, Glympse Bio, Terra Firma, Quest Diagnostics, Pandion Therapeutics, Surrozen, and Zomagen. G.S. has received grants from Gilead, Genfit, Intercept, Novartis, SignaBlok, and Shire; she also holds intellectual property rights with Up to Date..
Srinivasan Dasarathy
Pathobiology, Cleveland Clinic, Cleveland, United States
Competing interests
No competing interests declared.
Jose Carlos Garcia-Garcia
Life Sciences Transformative Platform Technologies, Procter and Gamble, Cincinatti, United States
Competing interests
Jose Carlos Garcia-Garcia, is an employee of The Procter & Gamble Co..
Daniel M. Rotroff
Research Core Services, Cleveland Clinic Lerner College of Medicine, Cleveland, United States
Competing interests
No competing interests declared.
Daniela S Allende
Department of Anatomical Pathology, Cleveland Clinic, Cleveland, United States
Competing interests
Daniela S Allende, Kaiser Permanente (CME lecture sessions)Advisory Board for Incyte (on treatment of cholangiocarcinoma).
Zeneng Wang
Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic Lerner College of Medicine, Cleveland, United States
Competing interests
Zeneng Wang, Z.W. report being named as co-inventor on pending and issued patents held by the Cleveland Clinic relating to cardiovascular diagnostics and therapeutics. Z.W. reports being eligible to receive royalty payments for inventions or discoveries related to cardiovascular diagnostics or therapeutics from Zehna Therapeutics, Cleveland Heart Lab, a wholly owned subsidiary of Quest Diagnostics, and Procter & Gamble..
Stanley L Hazen
Department of Cellular and Molecular Medicine, Cleveland Clinic Lerner College of Medicine, Cleveland, United States
Competing interests
Stanley L Hazen, S.L.H. report being named as co-inventor on pending and issued patents held by the Cleveland Clinic relating to cardiovascular diagnostics and therapeutics. S.L.H. reports being a paid consultant for Zehna Therapeutics, having received research funds from Zehna Therapeutics, Procter & Gamble, and Roche Diagnostics. S.L.H. report being eligible to receive royalty payments for inventions or discoveries related to cardiovascular diagnostics or therapeutics from Zehna Therapeutics, Cleveland Heart Lab, a wholly owned subsidiary of Quest Diagnostics, and Procter & Gamble..
Laura E Nagy
IDepartment of Inflammation and Immunity, Cleveland Clinic, Lerner Research Institute, Cleveland, United States
Competing interests
No competing interests declared.
Jonathan Mark Brown
Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic Lerner College of Medicine, Cleveland, United States
Competing interests
No competing interests declared.
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Animal experimentation: All mice were maintained in an Association for the Assessment and Accreditation of Laboratory Animal Care, International-approved animal facility. All experimental protocols were approved by the institutional animal care and use committee (IACUC) at the Cleveland Clinic.
Human subjects: Patients with AH were classified as moderate (MELD < 20, n=112) and severe (MELD {greater than or equal to}20, n=152) according to the MELD score at admission as part of either of two independent clinical trials (ClincalTrials.gov identifier # NCT01809132 and NCT03224949) or the NOAC biorepository. These studies were approved by the Institutional Review Boards of all 4 participating institutions and all study participants consented prior to collection of data and blood samples. Written informed consent was obtained from each patient included in the study and the study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki as reflected in a priori approval by the Institutional Review Boards at Johns Hopkins Medical Institutions.
© 2022, Helsley et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.